Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis

Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer

(2013) Xiaohua Wu et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Diagnostic Value of Human Epididymis Protein 4 Compared with Mesothelin for Ovarian Cancer: a Systematic Review and Meta-analysis

(2013) Jia-Ying Lin et al.   Asian Pacific Journal of Cancer Prevention

Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis

(2013) Elisabetta Bandiera et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Feasibility of large-scale screening using N-ERC/mesothelin levels in the blood for the early diagnosis of malignant mesothelioma

(2011) KOHTA IMASHIMIZU et al.   Experimental and Therapeutic Medicine

Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125

(2009) C. A. Shah et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of Yeast-Secreted In vivo Biotinylated Recombinant Antibodies (Biobodies) in Bead-Based ELISA

(2008) N. Scholler et al.   CLINICAL CANCER RESEARCH

Accuracy of CA 125 in the diagnosis of ovarian tumors: A quantitative systematic review

(2008) Lidia Rosi Medeiros et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

(2008) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

(2008) Martin Köbel et al.   PLOS MEDICINE

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY